|
1
|
Karsenty G and Wagner EF: Reaching a
genetic and molecular understanding of skeletal development. Dev
Cell. 2:389–406. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kular J, Tickner J, Chim SM and Xu J: An
overview of the regulation of bone remodelling at the cellular
level. Clin Biochem. 45:863–873. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Khan SN, Bostrom MP and Lane JM: Bone
growth factors. Orthop Clin North Am. 31:375–388. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lieberman JR, Daluiski A and Einhorn TA:
The role of growth factors in the repair of bone. Biology and
clinical applications. J Bone Joint Surg Am. 84-A:1–1044.
2002.PubMed/NCBI
|
|
5
|
Reddi AH, Roodman D, Freeman C and Mohla
S: Mechanisms of tumor metastasis to the bone: Challenges and
opportunities. J Bone Miner Res. 18:190–194. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Clemens TL and Chernausek SD: Genetic
strategies for elucidating insulin-like growth factor action in
bone. Growth Horm IGF Res. 14:195–199. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Niu T and Rosen CJ: The insulin-like
growth factor-I gene and osteoporosis: A critical appraisal. Gene.
361:38–56. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Noda T, Tokuda H, Yoshida M, Yasuda E,
Hanai Y, Takai S and Kozawa O: Possible involvement of
phosphatidylinositol 3-kinase/Akt pathway in insulin-like growth
factor-I-induced alkaline phosphatase activity in osteoblasts. Horm
Metab Res. 37:270–274. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hanai Y, Tokuda H, Ishisaki A,
Matsushima-Nishiwaki R, Nakamura N, Yoshida M, Takai S, Ohta T and
Kozawa O: Involvement of p44/p42 MAP kinase in insulin-like growth
factor-I-induced alkaline phosphatase activity in
osteoblast-like-MC3T3-E1 cells. Mol Cell Endocrinol. 251:42–48.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nakasaki M, Yoshioka K, Miyamoto Y, Sasaki
T, Yoshikawa H and Itoh K: IGF-I secreted by osteoblasts acts as a
potent chemotactic factor for osteoblasts. Bone. 43:869–879. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jankun J, Selman SH, Swiercz R and
Skrzypczak-Jankun E: Why drinking green tea could prevent cancer.
Nature. 387:5611997. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Koo SH and Montminy M: In vino veritas: A
tale of two sirt1s? Cell. 127:1091–1093. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
George SE, Ramalakshmi K and Mohan Rao LJ:
A perception on health benefits of coffee. Crit Rev Food Sci Nutr.
48:464–486. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Thielecke F and Boschmann M: The potential
role of green tea catechins in the prevention of the metabolic
syndrome - a review. Phytochemistry. 70:11–24. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shimizu M, Adachi S, Masuda M, Kozawa O
and Moriwaki H: Cancer chemoprevention with green tea catechins by
targeting receptor tyrosine kinases. Mol Nutr Food Res. 55:832–843.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Folwarczna J, Pytlik M, Zych M, Cegieła U,
Nowinska B, Kaczmarczyk-Sedlak I, Sliwinski L, Trzeciak H and
Trzeciak HI: Effects of caffeic and chlorogenic acids on the rat
skeletal system. Eur Rev Med Pharmacol Sci. 19:682–693.
2015.PubMed/NCBI
|
|
17
|
Kwak SC, Lee C, Kim JY, Oh HM, So HS, Lee
MS, Rho MC and Oh J: Chlorogenic acid inhibits osteoclast
differentiation and bone resorption by down-regulation of receptor
activator of nuclear factor κ-B ligand-induced nuclear factor of
activated T cells c1 expression. Biol Pharm Bull. 36:1779–1786.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shen CL, Yeh JK, Cao JJ and Wang JS: Green
tea and bone metabolism. Nutr Res. 29:437–456. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Singh R, Akhtar N and Haqqi TM: Green tea
polyphenol epigallocatechin-3-gallate: Inflammation and arthritis.
[corrected]. Life Sci. 86:907–918. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fujita K, Otsuka T, Yamamoto N, Kainuma S,
Ohguchi R, Kawabata T, Sakai G, Kuroyanagi G, Matsushima-Nishiwaki
R, Kozawa O, et al: (−)-Epigallocatechin gallate but not
chlorogenic acid upregulates osteoprotegerin synthesis through
regulation of bone morphogenetic protein-4 in osteoblasts. Exp Ther
Med. 14:417–423. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sudo H, Kodama HA, Amagai Y, Yamamoto S
and Kasai S: In vitro differentiation and calcification in a new
clonal osteogenic cell line derived from newborn mouse calvaria. J
Cell Biol. 96:191–198. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kozawa O, Tokuda H, Miwa M, Kotoyori J and
Oiso Y: Cross-talk regulation between cyclic AMP production and
phosphoinositide hydrolysis induced by prostaglandin E2 in
osteoblast-like cells. Exp Cell Res. 198:130–134. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Karagiosis SA, Chrisler WB, Bollinger N
and Karin NJ: Lysophosphatidic acid-induced ERK activation and
chemotaxis in MC3T3-E1 preosteoblasts are independent of EGF
receptor transactivation. J Cell Physiol. 219:716–723. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Laemmli UK: Cleavage of structural
proteins during the assembly of the head of bacteriophage T4.
Nature. 227:680–685. 1970. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kato K, Ito H, Hasegawa K, Inaguma Y,
Kozawa O and Asano T: Modulation of the stress-induced synthesis of
hsp27 and alpha B-crystallin by cyclic AMP in C6 rat glioma cells.
J Neurochem. 66:946–950. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kyriakis JM and Avruch J: Mammalian MAPK
signal transduction pathways activated by stress and inflammation:
A 10-year update. Physiol Rev. 92:689–737. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ip CK, Cheung AN, Ngan HY and Wong AS: p70
S6 kinase in the control of actin cytoskeleton dynamics and
directed migration of ovarian cancer cells. Oncogene. 30:2420–2432.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Alessi DR, Cuenda A, Cohen P, Dudley DT
and Saltiel AR: PD 098059 is a specific inhibitor of the activation
of mitogen-activated protein kinase kinase in vitro and in vivo. J
Biol Chem. 270:27489–27494. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li Y, Corradetti MN, Inoki K and Guan KL:
TSC2: Filling the GAP in the mTOR signaling pathway. Trends Biochem
Sci. 29:32–38. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Toker A and Newton AC: Cellular signaling:
Pivoting around PDK-1. Cell. 103:185–188. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shen CL, Wang P, Guerrieri J, Yeh JK and
Wang JS: Protective effect of green tea polyphenols on bone loss in
middle-aged female rats. Osteoporos Int. 19:979–990. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mah YJ, Song JS, Kim SO, Lee JH, Jeon M,
Jung UW, Moon SJ, Kim JH and Choi HJ: The effect of
epigallocatechin-3-gallate (EGCG) on human alveolar bone cells both
in vitro and in vivo. Arch Oral Biol. 59:539–549. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang CS, Chen L, Lee MJ, Balentine D, Kuo
MC and Schantz SP: Blood and urine levels of tea catechins after
ingestion of different amounts of green tea by human volunteers.
Cancer Epidemiol Biomarkers Prev. 7:351–354. 1998.PubMed/NCBI
|
|
34
|
Stalmach A, Williamson G and Crozier A:
Impact of dose on the bioavailability of coffee chlorogenic acids
in humans. Food Funct. 5:1727–1737. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhu Z, Huang P, Chong Y, George SK, Wen B,
Han N, Liu Z, Kang L and Lin N: Nucleus pulposus cells derived
IGF-1 and MCP-1 enhance osteoclastogenesis and vertebrae disruption
in lumbar disc herniation. Int J Clin Exp Pathol. 7:8520–8531.
2014.PubMed/NCBI
|
